Acetylon Pharmaceuticals acetylon.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180) Neuroscience Startups (947)

Acetylon Pharmaceuticals is a provider in the development of small molecule drugs targeting epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The Company's epigenetic drug discovery platform has yielded a portfolio of optimized, orally-administered Class I and Class II histone deacetylase (HDAC) selective compounds. Alteration of HDAC regulation through selective HDAC inhibition is thought to be applicable to a broad range of diseases ...Show all

Acetylon Pharmaceuticals is a provider in the development of small molecule drugs targeting epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The Company's epigenetic drug discovery platfor...Show all

Company (Acquired)

Phone: 617-245-1300

Fax:

70 Fargo Street
Suite 205
Boston, 02210
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Acetylon Pharmaceuticals $156.1M Dec 2, 2016
Xanthus Pharmaceuticals $63.8M Jun 9, 2008
HNC Software $0M May 2, 2002
See all 37 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Acetylon Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 37 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Phenyl and pyridinyl hydroxamic acids Jul 19, 2019 Feb 23, 2021 Patent
Combinations of histone deacetylase inhibitors and either her2 inhibitors or pi3k inhibitors Jun 22, 2016 Jul 28, 2020 Patent
Biomarkers to identify patients that will respond to treatment and treating such patients Apr 26, 2017 May 12, 2020 Patent
Crystalline forms of a histone deacetylase inhibitor Jun 08, 2016 Nov 05, 2019 Patent
Phenyl and pyridinyl hydroxamic acids Nov 09, 2017 Aug 06, 2019 Patent
See all 51 patents